FDA Inspection
Waylis TherapeuticsWaylis Therapeutics – FDA Inspection, Feb 12, 2026
Record Details
This FDA Inspection record concerns Waylis Therapeutics, with an inspection on February 12, 2026, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 9556879f-5f81-4433-881b-59a74b649726
Inspection Facts
- Inspection number
- 1303428
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.